1. PPIs and clopidogrel do not go hand in hand

   Clinical study 18 January 2013 Pages: 1 - 1

2. ADRAC warns of ADRs with botulinum toxin A

   News item 18 January 2013 Pages: 2 - 2

3. FDA advises against using Venom Hyperdrive 3.0

   Media release 18 January 2013 Pages: 2 - 2

4. Low reporting of fracture with PPI use - ADRAC

   News item 18 January 2013 Pages: 2 - 2

5. US FDA panel advises banning of two asthma drugs

   News item 18 January 2013 Pages: 2 - 2

6. Health Canada warns against using foreign health products

   News item 18 January 2013 Pages: 3 - 3

7. Psychotic/manic symptoms in ADHD may be ADRs

   Clinical study 18 January 2013 Pages: 3 - 3

8. Adalimumab/etanercept/infliximab

   Case report 18 January 2013 Pages: 4 - 4

9. Adenosine/verapamil

   Case report 18 January 2013 Pages: 4 - 4

10. Alendronic acid

    Case report 18 January 2013 Pages: 4 - 4

11. Antihyperglycaemics

    Case report 18 January 2013 Pages: 5 - 5

12. Antineoplastics

    Case report 18 January 2013 Pages: 5 - 5

13. Antineoplastics/dactinomycin/granulocyte colony-stimulating factors

    Case report 18 January 2013 Pages: 5 - 6

14. Antineoplastics/pirarubicin

    Case report 18 January 2013 Pages: 6 - 7

15. Antiretrovirals

    Case report 18 January 2013 Pages: 7 - 7

16. Antiretrovirals/hirsutine interaction

    Case report 18 January 2013 Pages: 7 - 7

17. Arsenic trioxide

    Case report 18 January 2013 Pages: 8 - 8

18. Atomoxetine/SLI 381

    Case report 18 January 2013 Pages: 8 - 8

19. Bevacizumab

    Case report 18 January 2013 Pages: 8 - 8

20. Cabergoline

    Case report 18 January 2013 Pages: 8 - 9

21. Cefdinir

    Case report 18 January 2013 Pages: 9 - 9

22. Clopidogrel/paroxetine interaction

    Case report 18 January 2013 Pages: 9 - 9

23. Cyproheptadine

    Case report 18 January 2013 Pages: 9 - 9

24. Cytarabine

    Case report 18 January 2013 Pages: 9 - 10

25. Deferiprone

    Case report 18 January 2013 Pages: 10 - 10

26. Dexamethasone/vincristine/pegaspargase

    Case report 18 January 2013 Pages: 10 - 10

27. Dobutamine/epinephrine/norepinephrine

    Case report 18 January 2013 Pages: 11 - 11

28. Donepezil

    Case report 18 January 2013 Pages: 11 - 11

29. Doxycycline

    Case report 18 January 2013 Pages: 11 - 11

30. Efalizumab

    Case report 18 January 2013 Pages: 11 - 12

31. Efalizumab withdrawal

    Case report 18 January 2013 Pages: 12 - 12

32. Enoxaparin sodium

    Case report 18 January 2013 Pages: 12 - 12

33. Epinephrine

    Case report 18 January 2013 Pages: 12 - 13

34. Epoetin α

    Case report 18 January 2013 Pages: 13 - 13

35. Escitalopram/olanzapine

    Case report 18 January 2013 Pages: 13 - 13

36. Esomeprazole/omeprazole

    Case report 18 January 2013 Pages: 14 - 14

37. Ethambutol

    Case report 18 January 2013 Pages: 14 - 14

38. Ethambutol

    Case report 18 January 2013 Pages: 14 - 15

39. Flecainide

    Case report 18 January 2013 Pages: 15 - 15

40. Fludarabine/melphalan/tacrolimus

    Case report 18 January 2013 Pages: 15 - 15

41. Fluindione

    Case report 18 January 2013 Pages: 15 - 16

42. Fluindione

    Case report 18 January 2013 Pages: 16 - 16

43. Fluorouracil/folinic acid/oxaliplatin

    Case report 18 January 2013 Pages: 16 - 16

44. Gemcitabine

    Case report 18 January 2013 Pages: 17 - 17

45. Heparin

    Case report 18 January 2013 Pages: 17 - 17

46. Hydroxycarbamide

    Case report 18 January 2013 Pages: 17 - 17

47. Imatinib

    Case report 18 January 2013 Pages: 17 - 17

48. Imatinib

    Case report 18 January 2013 Pages: 18 - 18

49. Imatinib

    Case report 18 January 2013 Pages: 18 - 18

50. Imatinib

    Case report 18 January 2013 Pages: 18 - 18